TABLE 4.
Comparison of the various antimicrobial agents against the 401 isolates of B. fragilis group
| Antimicrobial agent | MIC (μg/ml)
|
%Sa | |||
|---|---|---|---|---|---|
| Range | Mode | 50% | 90% | ||
| Piperacillin-tazobactam | ≤0.06–32 | 0.12 | 0.25 | 4 | 100 |
| Ampicillin-sulbactam | ≤0.03–>64 | 1 | 2 | 16 | 89 |
| Penicillin G | ≤0.015–>32 | 8 | 8 | >32 | 0 |
| Cefoxitin | ≤0.015–>32 | 4 | 4 | 16 | 92 |
| Imipenem | ≤0.015–8 | 0.03 | 0.06 | 0.25 | 99.8 |
| Meropenem | ≤0.015–>32 | 0.12 | 0.12 | 0.5 | 98.8 |
| Ciprofloxacin | ≤0.015–>32 | 4 | 8 | 32 | 10 |
| Trovafloxacin | ≤0.008–>16 | 0.25 | 0.25 | 2 | 92.8 |
| Clindamycin | ≤0.008–>16 | >16 | 1 | >16 | 71 |
| Metronidazole | ≤0.12–4 | 0.5 | 0.5 | 1 | 100 |
Percent susceptible isolates.